tiprankstipranks
Trending News
More News >
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
US Market
Advertisement

Defence Therapeutics (DTCFF) Technical Analysis

Compare
15 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Defence Therapeutics’s (DTCFF) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Defence Therapeutics is a Sell.
Defence Therapeutics’s (DTCFF) 20-Day exponential moving average is 0.49, while Defence Therapeutics’s (DTCFF) share price is $0.54, making it a Buy.
Defence Therapeutics’s (DTCFF) 50-Day exponential moving average is 0.51, while Defence Therapeutics’s (DTCFF) share price is $0.54, making it a Buy.

Defence Therapeutics (DTCFF) Pivot Points

Aug 30, 2025, 10:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.51
0.52
0.53
0.53
0.55
0.55
0.56
Fibonacci
0.52
0.52
0.53
0.53
0.54
0.54
0.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Defence Therapeutics (DTCFF) Moving Averages

Aug 30, 2025, 10:07 AM
Period
Simple
Exponential
MA5
0.54Buy
0.53Buy
MA10
0.49Buy
0.50Buy
MA20
0.47Buy
0.49Buy
MA50
0.48Buy
0.51Buy
MA100
0.58Sell
0.56Buy
MA200
0.62Sell
0.55Buy
Defence Therapeutics’s (DTCFF) 10-Day exponential moving average is 0.50, while Defence Therapeutics’s (DTCFF) share price is $0.54, making it a Buy.
Defence Therapeutics’s (DTCFF) 100-Day exponential moving average is 0.56, while Defence Therapeutics’s (DTCFF) share price is $0.54, making it a Buy.
Defence Therapeutics’s (DTCFF) stock price is $0.54 and Defence Therapeutics’s (DTCFF) 50-day simple moving average is 0.48, creating a Buy signal.
Defence Therapeutics’s (DTCFF) stock price is $0.54 and Defence Therapeutics’s (DTCFF) 100-day simple moving average is 0.58, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.54 and Defence Therapeutics’s (DTCFF) 200-day simple moving average is 0.62, creating a Sell signal.

Defence Therapeutics (DTCFF) Technical Indicators

Aug 30, 2025, 10:07 AM
Name
Value
Implied Action
RSI (14)
71.77
Sell
STOCH (9,6)
90.46
Sell
STOCHRSI (14)
90.46
Sell
MACD (12,26)
0.01
Sell
ADX (14)
42.60
Neutral
Williams %R
-9.84
Sell
CCI (14)
195.00
Sell
ATR (14)
0.04
-
Ultimate Oscillator
64.97
Neutral
ROC
21.28
Buy
Defence Therapeutics’s (DTCFF) Relative Strength Index (RSI) is 71.77, creating a Sell signal.
Defence Therapeutics’s (DTCFF) Trend Strength Indicator (ADX) is 42.60, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Commodity Channel Index (CCI) is 195.00, creating a Sell signal.
Defence Therapeutics’s (DTCFF) Price Rate of Change (ROC) is 21.28, creating a Buy signal.

FAQ

Is DTCFF a Buy, Hold, or Sell?
Based on DTCFF’s technical indicators, DTCFF is a Buy.
    What is DTCFF’s RSI (14)?
    DTCFF’s RSI (14) is 71.77, which suggests DTCFF is a Sell.
      What is DTCFF’s MACD?
      DTCFF’s MACD is 0.01, which suggests DTCFF is a Sell.
        What is DTCFF’s 5-day moving average?
        DTCFF’s 5-day moving average is 0.54, which suggests DTCFF is a Buy.
          What is DTCFF’s 20-day moving average?
          DTCFF 20-day moving average is 0.47, which suggests DTCFF is a Buy.
            What is DTCFF’s 50-day moving average?
            DTCFF’s 50-day moving average is 0.48, which suggests DTCFF is a Buy.
              What is DTCFF’s 200-day moving average?
              DTCFF’s 200-day moving average is 0.62, which suggests DTCFF is a Sell.
                What is DTCFF’s Williams % R (14)?
                DTCFF’s Williams % R (14) is -9.84, which suggests DTCFF is a Sell.
                  What is DTCFF’s CCI (14)?
                  DTCFF’s CCI (14) is 195.00, which suggests DTCFF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis